AU2002300359A1 - Fusion Protein Having Enhanced in vivo Activity of Erythropoietin - Google Patents

Fusion Protein Having Enhanced in vivo Activity of Erythropoietin

Info

Publication number: AU2002300359A1
Authority: AU; Australia
Prior art keywords: erythropoietin; enhanced; fusion protein; vivo activity; vivo
Prior art date: 2001-11-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002300359A

Other versions

AU2002300359B2 (en

Inventor

Bo-Sup Chung

Ki-Wan Kim

Dong-Eok Lee

Myung-Suk Oh

Ji-Sook Park

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

HK Inno N Corp

Original Assignee

CJ Healthcare Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-29

Filing date

2002-07-30

Publication date

2003-06-12

2001-11-29 Priority claimed from KR10-2001-0074975A external-priority patent/KR100467750B1/en

2002-07-30 Application filed by CJ Healthcare Corp filed Critical CJ Healthcare Corp

2003-06-12 Publication of AU2002300359A1 publication Critical patent/AU2002300359A1/en

2004-12-23 Application granted granted Critical

2004-12-23 Publication of AU2002300359B2 publication Critical patent/AU2002300359B2/en

2008-04-24 Assigned to CJ CHEILJEDANG CORP. reassignment CJ CHEILJEDANG CORP. Request for Assignment Assignors: CHEIL JEDANG CORPORATION

2014-10-02 Assigned to CJ HEALTHCARE CORPORATION reassignment CJ HEALTHCARE CORPORATION Request for Assignment Assignors: CJ CHEILJEDANG CORP.

2022-07-30 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

102000003951 Erythropoietin Human genes 0.000 title 1
108090000394 Erythropoietin Proteins 0.000 title 1
229940105423 erythropoietin Drugs 0.000 title 1
230000004927 fusion Effects 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1

AU2002300359A 2001-11-29 2002-07-30 Fusion Protein Having Enhanced in vivo Activity of Erythropoietin Ceased AU2002300359B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR2001-74975		2001-11-29
KR10-2001-0074975A KR100467750B1 (en)	2001-11-29	2001-11-29	Fusion protein having the enhanced in vivo activity of erythropoietin

Publications (2)

Publication Number	Publication Date
AU2002300359A1 true AU2002300359A1 (en)	2003-06-12
AU2002300359B2 AU2002300359B2 (en)	2004-12-23

Family

ID=36821313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002300359A Ceased AU2002300359B2 (en)	2001-11-29	2002-07-30	Fusion Protein Having Enhanced in vivo Activity of Erythropoietin

Country Status (23)

Country	Link
US (1)	US7098318B2 (en)
EP (1)	EP1319712B1 (en)
JP (1)	JP3860097B2 (en)
KR (1)	KR100467750B1 (en)
CN (1)	CN100390201C (en)
AR (1)	AR036384A1 (en)
AT (1)	ATE460483T1 (en)
AU (1)	AU2002300359B2 (en)
BR (1)	BRPI0203394B1 (en)
CA (1)	CA2394572C (en)
DE (2)	DE60235603D1 (en)
ES (1)	ES2339426T3 (en)
FR (1)	FR2832716B1 (en)
GB (1)	GB2382580B (en)
IT (1)	ITMI20021803A1 (en)
MX (1)	MXPA02008131A (en)
MY (1)	MY122935A (en)
NZ (1)	NZ520442A (en)
RU (1)	RU2225220C1 (en)
SG (1)	SG117416A1 (en)
TW (1)	TWI237056B (en)
WO (1)	WO2003046013A1 (en)
ZA (1)	ZA200206172B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7345019B1 (en) *	1999-04-13	2008-03-18	The Kenneth S. Warren Institute, Inc.	Modulation of excitable tissue function by peripherally administered erythropoietin
US7767643B2 (en)	2000-12-29	2010-08-03	The Kenneth S. Warren Institute, Inc.	Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en) *	2000-12-29	2003-04-17	Michael Brines	Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
EA010650B1 (en) *	2003-09-29	2008-10-30	Уоррен Фармасьютикалз, Инк.	Tissue protective cytokines for the treatment and preservations of sepsis and the formation of adhesions
US7625564B2 (en)	2006-01-27	2009-12-01	Novagen Holding Corporation	Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
US20150038413A1 (en)	2006-02-03	2015-02-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US9249407B2 (en)	2006-02-03	2016-02-02	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US8946155B2 (en)	2006-02-03	2015-02-03	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US9458444B2 (en)	2006-02-03	2016-10-04	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US10351615B2 (en)	2006-02-03	2019-07-16	Opko Biologics Ltd.	Methods of treatment with long-acting growth hormone
US10221228B2 (en)	2006-02-03	2019-03-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US20140113860A1 (en)	2006-02-03	2014-04-24	Prolor Biotech Ltd.	Long-acting polypeptides and methods of producing and administering same
US7553940B2 (en) *	2006-02-03	2009-06-30	Modigene Inc	Long-acting EPO polypeptides and derivatives thereof and methods thereof
US8067548B2 (en)	2007-07-26	2011-11-29	Novagen Holding Corporation	Fusion proteins having mutated immunoglobulin hinge region
CN101863982A (en) *	2009-04-17	2010-10-20	哈药集团生物工程有限公司	Fusion protein for increasing blood platelets and preparation method thereof
US9663778B2 (en)	2009-07-09	2017-05-30	OPKO Biologies Ltd.	Long-acting coagulation factors and methods of producing same
CN103864913A (en) *	2012-12-18	2014-06-18	联亚生技开发股份有限公司	Recombinant protein
WO2014159813A1 (en)	2013-03-13	2014-10-02	Moderna Therapeutics, Inc.	Long-lived polynucleotide molecules
US20150158926A1 (en)	2013-10-21	2015-06-11	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
IL301728A (en)	2015-06-19	2023-05-01	Opko Biologics Ltd	Long-acting coagulation factors and methods of producing same
CA3030533A1 (en)	2016-07-11	2018-01-18	Oren HERSHKOVITZ	Long-acting coagulation factor vii and methods of producing same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0461200T3 (en) *	1989-02-21	1997-03-10	Univ Washington	Modified forms of reproductive hormones
AU5355790A (en) *	1989-04-19	1990-11-16	Cetus Corporation	Multifunctional m-csf proteins and genes encoding therefor
US5856298A (en) *	1989-10-13	1999-01-05	Amgen Inc.	Erythropoietin isoforms
ZA946122B (en) *	1993-08-17	1995-03-20	Amgen Inc	Erythropoietin analogs
SG47030A1 (en) *	1994-01-03	1998-03-20	Genentech Inc	Thrombopoietin
ITFI940106A1 (en) *	1994-05-27	1995-11-27	Menarini Ricerche Sud Spa	HYBRID MOLECULE OF GM-CSF-L-EPO OR EPO-L-GM-CSF FORMULA FOR ERYTHROPOIETIC STIMULATION
JPH11500308A (en) *	1995-02-03	1999-01-12	ジー．ディー．サールアンドカンパニー	New c-MPL ligand
AU8182298A (en) *	1997-07-10	1999-02-08	Beth Israel Deaconess Medical Center	Recombinant erythropoietin / immunoglobulin fusion proteins
US6242570B1 (en) *	1997-07-10	2001-06-05	Beth Israel Deaconess Medical Center	Production and use of recombinant protein multimers with increased biological activity
BR9812267B1 (en) *	1997-07-14	2013-11-26		Recombinant Growth Hormone.
US6342220B1 (en) *	1997-08-25	2002-01-29	Genentech, Inc.	Agonist antibodies
AU3538799A (en) *	1998-04-30	1999-11-23	Kirin Brewery Company, Limited	Human thrombopoietin mutants
CA2379388C (en) *	1999-07-13	2012-05-29	George N. Cox, Iii	Immunoglobulin fusion proteins
CA2391080A1 (en) *	1999-11-12	2001-05-25	Merck Patent Gesellschaft Mit Beschraenkter Haftung	Erythropoietin forms with improved properties

2001
- 2001-11-29 KR KR10-2001-0074975A patent/KR100467750B1/en not_active IP Right Cessation
2002
- 2002-07-24 CA CA002394572A patent/CA2394572C/en not_active Expired - Fee Related
- 2002-07-26 WO PCT/KR2002/001420 patent/WO2003046013A1/en active Search and Examination
- 2002-07-26 TW TW091116686A patent/TWI237056B/en not_active IP Right Cessation
- 2002-07-30 NZ NZ520442A patent/NZ520442A/en not_active IP Right Cessation
- 2002-07-30 AU AU2002300359A patent/AU2002300359B2/en not_active Ceased
- 2002-07-30 MY MYPI20022857A patent/MY122935A/en unknown
- 2002-08-01 DE DE60235603T patent/DE60235603D1/en not_active Expired - Lifetime
- 2002-08-01 AT AT02016953T patent/ATE460483T1/en active
- 2002-08-01 EP EP02016953A patent/EP1319712B1/en not_active Expired - Lifetime
- 2002-08-01 ES ES02016953T patent/ES2339426T3/en not_active Expired - Lifetime
- 2002-08-01 SG SG200204673A patent/SG117416A1/en unknown
- 2002-08-01 DE DE10235248A patent/DE10235248B4/en not_active Expired - Fee Related
- 2002-08-02 FR FR0209867A patent/FR2832716B1/en not_active Expired - Lifetime
- 2002-08-02 ZA ZA200206172A patent/ZA200206172B/en unknown
- 2002-08-06 GB GB0218252A patent/GB2382580B/en not_active Expired - Fee Related
- 2002-08-08 IT IT001803A patent/ITMI20021803A1/en unknown
- 2002-08-20 BR BRPI0203394A patent/BRPI0203394B1/en not_active IP Right Cessation
- 2002-08-21 MX MXPA02008131A patent/MXPA02008131A/en active IP Right Grant
- 2002-08-23 CN CNB021301557A patent/CN100390201C/en not_active Expired - Fee Related
- 2002-08-29 US US10/230,454 patent/US7098318B2/en not_active Expired - Lifetime
- 2002-08-30 RU RU2002123438/15A patent/RU2225220C1/en not_active IP Right Cessation
- 2002-08-30 AR ARP020103279A patent/AR036384A1/en not_active Application Discontinuation
- 2002-08-30 JP JP2002253938A patent/JP3860097B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
AU2002300734A1 (en)	2003-06-12	Fusion protein having enhanced in vivo erythropoietin activity
AU2002300359A1 (en)	2003-06-12	Fusion Protein Having Enhanced in vivo Activity of Erythropoietin
ZA200206172B (en)	2003-04-03	Fusion protein having enhanced in vivo activity of erythropoietin.
AU2002363296A1 (en)	2003-05-12	Human secreted proteins
HUP0401300A3 (en)	2005-06-28	Bifunctional fusion proteins with glucocerebrosidase activity
AU6058500A (en)	2001-01-31	Fusion protein and uses thereof
AU2002329172A1 (en)	2003-01-08	Human secreted proteins
AU1608201A (en)	2001-05-30	Human zven proteins
AU2002251999A1 (en)	2002-09-12	Methods and compositions for the construction and use of fusion libraries using computational protein design methods
AU2067501A (en)	2001-06-25	Human oxidoreductase proteins
AU3923000A (en)	2000-11-02	Agp-1 fusion protein compositions and methods
AU2002305903A1 (en)	2002-12-09	Carbohydrate-associated proteins
AU2002322416A1 (en)	2003-03-03	Gfp fusion proteins and their use
AU2002311620A1 (en)	2003-01-21	Methods of making and using expression constructs for the expression of recombinant proteins
AU2002354363A1 (en)	2003-06-17	Method of activating protein
AU2003267356A1 (en)	2004-04-23	Proteins having polysaccharidase activity
AU2002240921A1 (en)	2002-08-12	Medane genes and proteins
AU2002357850A1 (en)	2003-06-30	Neurotransmission-associated proteins
AU2002360333A1 (en)	2003-05-12	Human angiomotin-like protein 1
AU2002257630A1 (en)	2002-09-24	Human mrp5-like protein
AU2002351616A1 (en)	2003-07-15	Lipase genes and proteins
AU2002242870A1 (en)	2002-10-08	Nucleic acids encoding human est1 proteins
AU2002357873A1 (en)	2003-07-15	Carbohydrate-associated proteins
AU2002326909A1 (en)	2003-04-01	Neurotransmission-associated proteins
AU2002357145A1 (en)	2003-07-09	Therapeutic protein and nucleic acid